Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma

Correlation with Gleason staging

Uddhav P. Kelavkar, Cynthia Cohen, Hideki Kamitani, Thomas E. Eling, Kamal F. Badr

Research output: Contribution to journalArticle

Abstract

We recently reported that the mutant form of the tumor-suppressor gene p53 up-regulates 15-LO-1 gene expression in a murine cell line. Here, we examine the expression of 15-lipoxygenase (LO)-1 and mutant p53 (mtp53) in human prostatic tissues and 15-LO-1 in the human prostate adenocarcinoma cell line PC-3. Reverse transcription-PCR and western analyses conclusively demonstrated expression of 15-LO-1 in PC-3 cells. Western blotting for 15-LO-1 in freshly resected 'normal' and prostate adenocarcinoma specimens showed 15-LO-1 expression in normal tissue, but significantly higher levels were detected in prostate adenocarcinomas. Prostate adenocarcinoma tissues generated chirally pure 13-S-hydroxyoctadecadienoic acid from exogenous linoleic acid, a preferred substrate of 15-LO-1. To study the correlation of 15-LO-1 expression with mtp53 in prostate cancer, we immunostained 48 prostatectomy specimens obtained by transurethral resection of the prostate and needle biopsy (median age 68 years, range 52-93) of different Gleason grades (n = 48), using antibodies specific for 15-LO-1, mtp53 and MIB-1 (a proliferation marker). We compared staining in cancerous foci with adjacent normal appearing prostate tissues. In only 5 of 48 patients did 'normal' tissue adjacent to cancerous foci display staining for 15-LO-1. However, no staining for mtp53 was observed in any of the normal tissues. In cancer foci, robust staining was observed for both 15-LO-1 (36 of 48, 75%) and mtp53 (19 of 48, 39%). Furthermore, the intensities of expression of 15-LO-1 and mtp53 correlated positively with each other (P

Original languageEnglish (US)
Pages (from-to)1777-1787
Number of pages11
JournalCarcinogenesis
Volume21
Issue number10
StatePublished - 2000
Externally publishedYes

Fingerprint

Arachidonate 15-Lipoxygenase
Lipoxygenase
Prostate
Adenocarcinoma
Staining and Labeling
Cell Line
Transurethral Resection of Prostate
Needle Biopsy
Linoleic Acid
Prostatectomy
Tumor Suppressor Genes
Reverse Transcription

ASJC Scopus subject areas

  • Cancer Research

Cite this

Kelavkar, U. P., Cohen, C., Kamitani, H., Eling, T. E., & Badr, K. F. (2000). Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: Correlation with Gleason staging. Carcinogenesis, 21(10), 1777-1787.

Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma : Correlation with Gleason staging. / Kelavkar, Uddhav P.; Cohen, Cynthia; Kamitani, Hideki; Eling, Thomas E.; Badr, Kamal F.

In: Carcinogenesis, Vol. 21, No. 10, 2000, p. 1777-1787.

Research output: Contribution to journalArticle

Kelavkar, UP, Cohen, C, Kamitani, H, Eling, TE & Badr, KF 2000, 'Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: Correlation with Gleason staging', Carcinogenesis, vol. 21, no. 10, pp. 1777-1787.
Kelavkar, Uddhav P. ; Cohen, Cynthia ; Kamitani, Hideki ; Eling, Thomas E. ; Badr, Kamal F. / Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma : Correlation with Gleason staging. In: Carcinogenesis. 2000 ; Vol. 21, No. 10. pp. 1777-1787.
@article{53667a6cd5404fe9aec600df152cff8a,
title = "Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: Correlation with Gleason staging",
abstract = "We recently reported that the mutant form of the tumor-suppressor gene p53 up-regulates 15-LO-1 gene expression in a murine cell line. Here, we examine the expression of 15-lipoxygenase (LO)-1 and mutant p53 (mtp53) in human prostatic tissues and 15-LO-1 in the human prostate adenocarcinoma cell line PC-3. Reverse transcription-PCR and western analyses conclusively demonstrated expression of 15-LO-1 in PC-3 cells. Western blotting for 15-LO-1 in freshly resected 'normal' and prostate adenocarcinoma specimens showed 15-LO-1 expression in normal tissue, but significantly higher levels were detected in prostate adenocarcinomas. Prostate adenocarcinoma tissues generated chirally pure 13-S-hydroxyoctadecadienoic acid from exogenous linoleic acid, a preferred substrate of 15-LO-1. To study the correlation of 15-LO-1 expression with mtp53 in prostate cancer, we immunostained 48 prostatectomy specimens obtained by transurethral resection of the prostate and needle biopsy (median age 68 years, range 52-93) of different Gleason grades (n = 48), using antibodies specific for 15-LO-1, mtp53 and MIB-1 (a proliferation marker). We compared staining in cancerous foci with adjacent normal appearing prostate tissues. In only 5 of 48 patients did 'normal' tissue adjacent to cancerous foci display staining for 15-LO-1. However, no staining for mtp53 was observed in any of the normal tissues. In cancer foci, robust staining was observed for both 15-LO-1 (36 of 48, 75{\%}) and mtp53 (19 of 48, 39{\%}). Furthermore, the intensities of expression of 15-LO-1 and mtp53 correlated positively with each other (P",
author = "Kelavkar, {Uddhav P.} and Cynthia Cohen and Hideki Kamitani and Eling, {Thomas E.} and Badr, {Kamal F.}",
year = "2000",
language = "English (US)",
volume = "21",
pages = "1777--1787",
journal = "Carcinogenesis",
issn = "0143-3334",
publisher = "Oxford University Press",
number = "10",

}

TY - JOUR

T1 - Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma

T2 - Correlation with Gleason staging

AU - Kelavkar, Uddhav P.

AU - Cohen, Cynthia

AU - Kamitani, Hideki

AU - Eling, Thomas E.

AU - Badr, Kamal F.

PY - 2000

Y1 - 2000

N2 - We recently reported that the mutant form of the tumor-suppressor gene p53 up-regulates 15-LO-1 gene expression in a murine cell line. Here, we examine the expression of 15-lipoxygenase (LO)-1 and mutant p53 (mtp53) in human prostatic tissues and 15-LO-1 in the human prostate adenocarcinoma cell line PC-3. Reverse transcription-PCR and western analyses conclusively demonstrated expression of 15-LO-1 in PC-3 cells. Western blotting for 15-LO-1 in freshly resected 'normal' and prostate adenocarcinoma specimens showed 15-LO-1 expression in normal tissue, but significantly higher levels were detected in prostate adenocarcinomas. Prostate adenocarcinoma tissues generated chirally pure 13-S-hydroxyoctadecadienoic acid from exogenous linoleic acid, a preferred substrate of 15-LO-1. To study the correlation of 15-LO-1 expression with mtp53 in prostate cancer, we immunostained 48 prostatectomy specimens obtained by transurethral resection of the prostate and needle biopsy (median age 68 years, range 52-93) of different Gleason grades (n = 48), using antibodies specific for 15-LO-1, mtp53 and MIB-1 (a proliferation marker). We compared staining in cancerous foci with adjacent normal appearing prostate tissues. In only 5 of 48 patients did 'normal' tissue adjacent to cancerous foci display staining for 15-LO-1. However, no staining for mtp53 was observed in any of the normal tissues. In cancer foci, robust staining was observed for both 15-LO-1 (36 of 48, 75%) and mtp53 (19 of 48, 39%). Furthermore, the intensities of expression of 15-LO-1 and mtp53 correlated positively with each other (P

AB - We recently reported that the mutant form of the tumor-suppressor gene p53 up-regulates 15-LO-1 gene expression in a murine cell line. Here, we examine the expression of 15-lipoxygenase (LO)-1 and mutant p53 (mtp53) in human prostatic tissues and 15-LO-1 in the human prostate adenocarcinoma cell line PC-3. Reverse transcription-PCR and western analyses conclusively demonstrated expression of 15-LO-1 in PC-3 cells. Western blotting for 15-LO-1 in freshly resected 'normal' and prostate adenocarcinoma specimens showed 15-LO-1 expression in normal tissue, but significantly higher levels were detected in prostate adenocarcinomas. Prostate adenocarcinoma tissues generated chirally pure 13-S-hydroxyoctadecadienoic acid from exogenous linoleic acid, a preferred substrate of 15-LO-1. To study the correlation of 15-LO-1 expression with mtp53 in prostate cancer, we immunostained 48 prostatectomy specimens obtained by transurethral resection of the prostate and needle biopsy (median age 68 years, range 52-93) of different Gleason grades (n = 48), using antibodies specific for 15-LO-1, mtp53 and MIB-1 (a proliferation marker). We compared staining in cancerous foci with adjacent normal appearing prostate tissues. In only 5 of 48 patients did 'normal' tissue adjacent to cancerous foci display staining for 15-LO-1. However, no staining for mtp53 was observed in any of the normal tissues. In cancer foci, robust staining was observed for both 15-LO-1 (36 of 48, 75%) and mtp53 (19 of 48, 39%). Furthermore, the intensities of expression of 15-LO-1 and mtp53 correlated positively with each other (P

UR - http://www.scopus.com/inward/record.url?scp=0033783018&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033783018&partnerID=8YFLogxK

M3 - Article

VL - 21

SP - 1777

EP - 1787

JO - Carcinogenesis

JF - Carcinogenesis

SN - 0143-3334

IS - 10

ER -